Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Graft vs Host Disease × Idarubicin × 1 year × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 35 Myelodysplastic Syndromes 6 Leukemia, Biphenotypic, Acute 5 Leukemia 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Myelomonocytic, Acute 3 Neoplasm, Residual 2 Myeloproliferative Disorders 2 Leukemia, Monocytic, Acute 2 Leukemia, Megakaryoblastic, Acute 2 Leukemia, Erythroblastic, Acute 2 Congenital Abnormalities 2 Sarcoma, Myeloid 1 Neoplasms by Histologic Type 1 Myelodysplastic-Myeloproliferative Diseases 1 Lymphoma 1 Liver Neoplasms 1 Leukemia, Myeloid 1 Leukemia, Eosinophilic, Acute 1 Leukemia, Basophilic, Acute 1 Hematologic Neoplasms 1 Down Syndrome 1 Carcinoma, Hepatocellular 1 Blast Crisis 1 Anemia, Refractory, with Excess of Blasts 1

Interventions

Cyclophosphamide 14 Mycophenolic Acid 10 Tacrolimus 9 fludarabine 7 ruxolitinib 6 Whole-Body Irradiation 5 Melphalan 5 Busulfan 5 fludarabine phosphate 4 Sirolimus 4 Methotrexate 4 Hematopoietic Stem Cell Transplantation 3 ibrutinib 2 Thiotepa 2 Stem Cell Transplantation 2 Specimen Handling 2 Radiotherapy 2 Cyclosporine 2 Biopsy 2 Abatacept 2 vedolizumab 1 tildrakizumab 1 itacitinib 1 interferon gamma-1b 1 blinatumomab 1 belumosudil 1 axatilimab 1 Vorinostat 1 Tomography, Optical Coherence 1 Therapeutics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡